News
Partner Organisations
Consensus Statement: NCDs and Immunisation – Advancing Coordinated Advocacy and Action
Provides a shared foundation for advancing adult immunisation as an important component of healthier ageing, NCD prevention, management, and care.
News
Reports
Partner Organisations
EHMA: Prepact - A Receptivity Assessment for HMPV and RSV Diagnosis in Older Adults
EMA White Paper assessing receptivity to improving testing and surveillance for RSV & HMPV across Europe, with a specific focus on older adults.
(Recording available) IDC Partner Session at WOHC2026 - Exploring bidirectional links between respiratory viruses & non-communicable diseases
Now available to watch On Demand - IDC session at 9th World One Health Congress in Lisbon, 6 September 2026.
In the media
News
Reports
Demographic transformation in the EU: challenges and opportunities
European population declining, but living longer than ever
Cost-Effectiveness Analysis of the High-Dose Trivalent Influenza Vaccine in the Elderly Population in Italy
The findings suggest that the high-dose vaccine may improve health outcomes while reducing healthcare costs in people aged 65 and over in Italy.
High-Dose vs Standard-Dose Influenza Vaccines in Older Adults: A Meta-Analysis
Among adults 65 years and older, does high-dose inactivated influenza vaccine (HD-IIV) provide superior protection against hospitalization and mortality compared with the standard dose?
Influenza Vaccine and Associated Infection and Death in California, 2024 to 2025
Among adults aged 65 years and older with laboratory confirmed influenza, vaccination was associated with 29% lower likelihood of death due to influenza-related causes.
Cost-effectiveness of high-dose influenza vaccination in the Netherlands: Updated analysis incorporating new evidence
HD-IIV remains cost-effective in Dutch adults aged ≥60.